Your Waterstones card is changing, introducing...
Biological Models in Radiopharmaceutical Development - Developments in Nuclear Medicine 27 (Paperback)
  • Biological Models in Radiopharmaceutical Development - Developments in Nuclear Medicine 27 (Paperback)

Biological Models in Radiopharmaceutical Development - Developments in Nuclear Medicine 27 (Paperback)

Paperback 272 Pages / Published: 20/09/2011
  • We can order this

Usually despatched within 3 weeks

  • This item has been added to your basket
Radiophannaceuticals labeled with short-lived radionuclides are utilized to unravel biochemical processes, and to diagnosis and treat diseases of the living body are-developed through extensive evaluation in ~iological models. 'fhC first attempt to compile information was a volume entitled ANIMAL MODELS IN RADIOTRACER DESIGN that was edited by William C. Eckelman and myself in 1983. The volume had a focus on the animal models that investigators were using in order to design radiotracers that displayed in vivo selectivity as measured by biodistribution and pharmacokinetic studies. A concern in the early days of nuclear medicine was species differences. Often a series of labeled compounds were evaluated in a several different animal models in order to gain confidence that the selected radiotracer would behave appropriately in humans. During the past 12 years there have been remarkable advances in molecular genetics, molecular biology, synthetic radiopharmaceutical chemistry, molecular modeling and visualization, and emission tomography. Biological models can now be selected that are better defined in terms of molecular aspects of the disease process. The development of high resolution PET and SPET for clinical applications facilitates the development of new radiopharmaceuticals by the use of models to quantitatively evaluate drug effects, and progression of disease, and hence to arrive at better diagnosis and treatments for animals and humans. With these advances there is an effective use of biological models, and the refinement of alternatives for the development of new radiophannaceuticals.

Publisher: Springer
ISBN: 9789401065580
Number of pages: 272
Weight: 463 g
Dimensions: 240 x 160 x 15 mm
Edition: Softcover reprint of the original 1st ed. 199

`This is an original and unique reference book with high practical value for researchers in the field. Those who have dealt with the problem of finding an appropriate animal model for a certain study will especially appreciate this book. This book is an absolute `must' for those involved in preclinical development and biological testing of radiopharmaceuticals.'
European Journal of Nuclear Medicine, 23:7 (1996)

You may also be interested in...

Abdominal Ultrasound
Added to basket
Chest X-rays for Medical Students
Added to basket
Making Sense of Echocardiography
Added to basket
Cardiovascular Magnetic Resonance
Added to basket
Chest X-Ray Made Easy
Added to basket
Making Sense of the ECG
Added to basket
MRI of the Musculoskeletal System
Added to basket
The Unofficial Guide to Radiology
Added to basket
Core Radiology
Added to basket
Unofficial Guide to Radiology
Added to basket
Analyzing Neural Time Series Data
Added to basket
Basic Guide to Dental Radiography
Added to basket
Diagnostic Imaging 7E
Added to basket


Please sign in to write a review

Your review has been submitted successfully.